Dynavax Reports Third Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Dynavax Technologies (DVAX) PT Raised to $30 at Cowen
November 5, 2021 6:45 AM EDTCowen analyst Phil Nadeau raised the price target on Dynavax Technologies (NASDAQ: DVAX) to $30.00 (from $20.00) while maintaining an Outperform rating.
The analyst commented, "DVAX reported Q3 Heplisav rev. of $22.7MM, above consensus ($15MM) as share at targeted accounts increased to... More
Dynavax (DVAX) Reports Q3 Loss of $0.24/sh
November 4, 2021 5:31 PM EDTDynavax (NASDAQ: DVAX) reported Q3 EPS of ($0.24), versus ($0.15) reported last year. Revenue for the quarter came in at $108.3 million, versus $13.41 million reported last year.
For earnings history and earnings-related data on Dynavax (DVAX) click here.
... More